Filing Details

Accession Number:
0001127602-14-024309
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-07-31 17:49:10
Reporting Period:
2014-07-30
Filing Date:
2014-07-31
Accepted Time:
2014-07-31 16:49:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
816956 Conmed Corp CNMD Electromedical & Electrotherapeutic Apparatus (3845) 160977505
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1222114 J Joseph Corasanti 101 Winship Road
New Hartford NY 13413
Former President & Ceo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-07-30 5,000 $0.00 137,685 No 4 M Direct
Common Stock Disposition 2014-07-30 2,534 $39.38 135,151 No 4 F Direct
Common Stock Acquisiton 2014-07-30 10,000 $0.00 145,151 No 4 M Direct
Common Stock Disposition 2014-07-30 5,067 $39.38 140,084 No 4 F Direct
Common Stock Acquisiton 2014-07-30 15,000 $0.00 155,084 No 4 M Direct
Common Stock Disposition 2014-07-30 7,601 $39.38 147,483 No 4 F Direct
Common Stock Acquisiton 2014-07-30 20,000 $0.00 167,483 No 4 M Direct
Common Stock Disposition 2014-07-30 10,134 $39.38 157,349 No 4 F Direct
Common Stock Acquisiton 2014-07-30 16,250 $0.00 173,599 No 4 M Direct
Common Stock Disposition 2014-07-30 8,234 $39.38 165,365 No 4 F Direct
Common Stock Acquisiton 2014-07-30 62,500 $19.93 227,865 No 4 M Direct
Common Stock Disposition 2014-07-30 47,273 $39.38 180,592 No 4 F Direct
Common Stock Acquisiton 2014-07-30 62,500 $29.92 243,092 No 4 M Direct
Common Stock Disposition 2014-07-30 55,095 $39.38 187,997 No 4 F Direct
Common Stock Acquisiton 2014-07-30 62,500 $26.69 250,497 No 4 M Direct
Common Stock Disposition 2014-07-30 52,566 $39.38 197,931 No 4 F Direct
Common Stock Acquisiton 2014-07-30 62,500 $16.46 260,431 No 4 M Direct
Common Stock Disposition 2014-07-30 44,556 $39.38 215,875 No 4 F Direct
Common Stock Acquisiton 2014-07-30 40,000 $21.19 255,875 No 4 M Direct
Common Stock Disposition 2014-07-30 30,886 $39.38 224,989 No 4 F Direct
Common Stock Acquisiton 2014-07-30 62,500 $19.26 287,489 No 4 M Direct
Common Stock Disposition 2014-07-30 46,749 $39.38 240,740 No 4 F Direct
Common Stock Acquisiton 2014-07-30 62,500 $27.63 303,240 No 4 M Direct
Common Stock Disposition 2014-07-30 53,302 $39.38 249,938 No 4 F Direct
Common Stock Acquisiton 2014-07-30 62,500 $26.09 312,438 No 4 M Direct
Common Stock Disposition 2014-07-30 52,096 $39.38 260,342 No 4 F Direct
Common Stock Acquisiton 2014-07-30 62,500 $32.93 322,842 No 4 M Direct
Common Stock Disposition 2014-07-30 57,451 $39.38 265,391 No 4 F Direct
Common Stock Disposition 2014-07-30 109,035 $39.25 156,356 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 M Direct
No 4 F Direct
No 4 M Direct
No 4 F Direct
No 4 M Direct
No 4 F Direct
No 4 M Direct
No 4 F Direct
No 4 M Direct
No 4 F Direct
No 4 M Direct
No 4 F Direct
No 4 M Direct
No 4 F Direct
No 4 M Direct
No 4 F Direct
No 4 M Direct
No 4 F Direct
No 4 M Direct
No 4 F Direct
No 4 M Direct
No 4 F Direct
No 4 M Direct
No 4 F Direct
No 4 M Direct
No 4 F Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Rsus (restricted Stock Units) Disposition 2014-07-30 5,000 $0.00 5,000 $0.00
Common Stock Rsus (restricted Stock Units) Disposition 2014-07-30 10,000 $0.00 10,000 $0.00
Common Stock Rsus (restricted Stock Units) Disposition 2014-07-30 15,000 $0.00 15,000 $0.00
Common Stock Rsus (restricted Stock Units) Disposition 2014-07-30 20,000 $0.00 20,000 $0.00
Common Stock Rsus (restricted Stock Units) Disposition 2014-07-30 16,250 $0.00 16,250 $0.00
Common Stock Sars (Stock Appreciation Rights) Disposition 2014-07-30 62,500 $0.00 62,500 $19.93
Common Stock Sars (Stock Appreciation Rights) Disposition 2014-07-30 62,500 $0.00 62,500 $29.92
Common Stock Sars (Stock Appreciation Rights) Disposition 2014-07-30 62,500 $0.00 62,500 $26.69
Common Stock Sars (Stock Appreciation Rights) Disposition 2014-07-30 62,500 $0.00 62,500 $16.46
Common Stock Sars (Stock Appreciation Rights) Disposition 2014-07-30 40,000 $0.00 40,000 $21.19
Common Stock Sars (Stock Appreciation Rights) Disposition 2014-07-30 62,500 $0.00 62,500 $19.26
Common Stock Sars (Stock Appreciation Rights) Disposition 2014-07-30 62,500 $0.00 62,500 $27.63
Common Stock Sars (Stock Appreciation Rights) Disposition 2014-07-30 62,500 $0.00 62,500 $26.09
Common Stock Sars (Stock Appreciation Rights) Disposition 2014-07-30 62,500 $0.00 62,500 $32.93
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2020-06-01 No 4 M Direct
0 2021-06-01 No 4 M Direct
0 2022-06-01 No 4 M Direct
0 2023-06-01 No 4 M Direct
0 2024-06-01 No 4 M Direct
0 2016-05-16 No 4 M Direct
0 2017-05-17 No 4 M Direct
0 2018-06-01 No 4 M Direct
0 2019-06-01 No 4 M Direct
0 2019-10-30 No 4 M Direct
0 2020-06-01 No 4 M Direct
0 2021-06-01 No 4 M Direct
0 2022-06-01 No 4 M Direct
0 2023-06-01 No 4 M Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.00 to $39.35. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder.
  2. Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan, with the RSUs generally vesting over a five year period with the first 20% of the RSU's vesting one year after the grant date.
  3. According to Section 2(d) of the Separation and Release Agreement dated July 22, 2014, and attached as Exhibit 10.1 of the Form 8-K dated July 23, 2014, all of Mr. Joseph Corasanti's unvested RSUs and SARs accelerated, other than the 2014 SARS which were cancelled.
  4. The stock appreciation rights ("SARs") were granted under the Issuer's 2006 Stock Incentive Plan and generally vest in equal amounts over a five year period.
  5. The stock appreciation rights ("SARs") were granted under the Company's 2006 Stock Incentive Plan and generally vest in equal amounts over a five year period.
  6. The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.
  7. The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a period with the first 20% tranche to vest on June 1, 2010 with each successive 20% tranche to vest on June 1 the following year.